Table 1 Summary of study demographics

From: Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections

Variable	Placebo	Active	P-value
Total enrolled	44	50	-
Male	24 (54.5%)	24 (48.0%)	1.0^*
Female	20 (45.5%)	26 (52.0%)	.466^*
Age (Mean ± SD)	24.86 ± 6.47	25.14 ± 6.73	.807^†
Age range	18-43	18-43

^*Chi square test, asymptotic significance
^†Independent samples t-test

Back to article page